NUDT15 c.415C>T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia

• Kanhatai Chiengthong,
• Chupong Ittiwut,
• Sasipa Muensri,
• Jiratchaya Sophonphan,
• Darintr Sosothikul,
• Panya Seksan,
• Koramit Suppipat,
• Kanya Suphapeetiporn,
• Vorasuk Shotelersuk

Affiliations

Kanhatai Chiengthong

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok

Chupong Ittiwut

Central Laboratory, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok

Sasipa Muensri

Central Laboratory, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok

Jiratchaya Sophonphan

Department of Biostatistics, HIV Netherlands Australia Thailand (HIV-NAT) Research Collaboration, Thai Red Cross AIDS Research Center, Bangkok

Darintr Sosothikul

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok

Panya Seksan

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok

Koramit Suppipat

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok

Kanya Suphapeetiporn

Center of Excellence for Medical Genetics, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok;Excellence Center for Medical Genetics, King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand

Vorasuk Shotelersuk

Center of Excellence for Medical Genetics, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok;Excellence Center for Medical Genetics, King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand